Literature DB >> 7793510

Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.

J L Weissman1, C A Jungreis, J T Johnson.   

Abstract

This article describes a woman with hemorrhagic telangiectasia, or Osler-Weber-Rendu disease, with recurrent nosebleeds despite prior septal dermoplasty and laser treatments. Telangiectasias were clearly shown at the time of angiography. Embolization of abnormal vessels on both sides resulted in cessation of epistaxis for many months. Bilateral studies are important, even when the epistaxis seems to be unilateral.

Entities:  

Mesh:

Year:  1995        PMID: 7793510     DOI: 10.1016/0196-0709(95)90047-0

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  4 in total

1.  First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Basel Al Kadah; George Papaspyrou; Mathias Schneider; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-23       Impact factor: 2.503

2.  Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.

Authors:  Ilias Karapantzos; Nikolaos Tsimpiris; Dimitrios G Goulis; Helen Van Hoecke; Paul Van Cauwenberge; Vasilis Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-01       Impact factor: 2.503

3.  Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Authors:  K F Layton; D F Kallmes; L A Gray; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

4.  Treatment of the skin manifestations of hereditary hemorrhagic telangiectasia with pulsed dye laser.

Authors:  Shlomit Halachmi; Hadar Israeli; Dan Ben-Amitai; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-05-17       Impact factor: 3.161

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.